Bloomberg calculated the 50 top overseas cash holders on the S&P 500 — which totaled $925 billion.
Medtronic reported $6 billion in cash held overseas, 43.8 percent of the company’s total cash as reported in their latest filings. The company’s cash overseas remains flat compared to last year. Other notable healthcare companies on the list include Johnson & Johnson with $41.3 billion in cash held overseas and Celene with $6.9 million.
Stryker ranked No. 41 on the list with $2.8 billion in cash held overseas, a 30.8 percent increase over the last filings. About 85 percent of Stryker’s cash is held overseas.
The top 10 companies with the most cash held overseas are:
1. Apple: $239.6 billion
2. Microsoft: $122.2 billion
3. Cisco Systems: $65.1 billion
4. Alphabet: $55.7 billion
5. Oracle: $52.2 billion
6. Johnson & Johnson: $41.3 billion
7. General Electric: $35 billion
8. Amgen: $35 billion
9. Gilead Sciences: $29.3 billion
10. Qualcomm: $26.8 billion
More articles on device companies:
Global spinal fusion devices market valued at $7.4M by 2022
Caber Spine Technologies fills 2 newly created sales director roles
48 orthopedic devices receive FDA 510(k) clearance in May
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
